Cyclin H Antikörper (AA 1-323)
Kurzübersicht für Cyclin H Antikörper (AA 1-323) (ABIN5621517)
Target
Alle Cyclin H (CCNH) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Bindungsspezifität
- AA 1-323
- 
                                            Produktmerkmale
- Mouse Monoclonal Cyclin H antibody
- 
                                            Aufreinigung
- Cyclin H antibody was purified by protein A affinity chromatography
- 
                                            Immunogen
- Cyclin H antibody was raised in Mouse using recombinant human Cyclin H (1-323aa), purified from E.coli, as the immunogen
- 
                                            Isotyp
- IgG2b kappa
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- Supplied in liquid form in Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % Glycerol
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- 4 °C/-20 °C
- 
                                            Informationen zur Lagerung
- Store at 4 deg C for short term storage or -20 deg C for long term storage
 
- 
                                            
- 
    - Cyclin H (CCNH)
- 
                                            Andere Bezeichnung
- Cyclin H
- 
                                            Pathways
- Zellzyklus, Mitotic G1-G1/S Phases, M Phase
 Target
- 
                    
 
                                     
                                     
                                    